id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-P-0043-0007,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4ac
FDA-1994-P-0043-0006,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:15Z,,0,0,09000064804ff4ab
FDA-1994-P-0043-0008,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:16Z,,0,0,09000064804ff4ad
FDA-1994-P-0043-0004,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:16Z,,0,0,09000064804ff4a9
FDA-1994-P-0043-0010,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:18Z,,0,0,09000064804ff4af
FDA-1994-P-0043-0005,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4aa
FDA-1994-P-0043-0009,FDA,FDA-1994-P-0043,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-12-28T05:00:00Z,1995,12,1995-12-28T05:00:00Z,1996-03-21T04:59:59Z,2008-05-16T23:21:21Z,,0,0,09000064804ff4ae
FDA-1980-N-0074-0035,FDA,FDA-1980-N-0074,FDA,Notice,NCR-Notice of Correction,1995-12-05T05:00:00Z,1995,12,,,2008-05-30T22:53:09Z,,0,0,09000064805bb3ca
FDA-1993-N-0064-0002,FDA,FDA-1993-N-0064,FDA,Notice,NEC-Notice of Extension,1995-12-05T05:00:00Z,1995,12,1995-11-24T05:00:00Z,1995-12-23T04:59:59Z,2008-05-16T23:24:21Z,,0,0,09000064804fca32
FDA-1993-N-0064-0001,FDA,FDA-1993-N-0064,FDA,Notice,NEC-Notice of Extension,1995-12-05T05:00:00Z,1995,12,1995-11-24T05:00:00Z,1995-12-23T04:59:59Z,2008-05-16T23:24:20Z,,0,0,09000064804fc9b0
FDA-1988-P-0013-0004,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475b27
FDA-1988-P-0013-0006,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:00Z,,0,0,0900006480475b29
FDA-1995-N-0049-0001,FDA,FDA-1995-N-0049,Beverages: Bottled Water,Notice,NPR-Notice of Proposed Rule-Making,1995-11-29T05:00:00Z,1995,11,1995-11-13T05:00:00Z,1996-01-30T04:59:59Z,2024-07-16T14:08:13Z,95-27799,0,0,0900006480561cac
FDA-1988-P-0013-0005,FDA,FDA-1988-P-0013,FDA,Notice,NFR-Notice of Final Rule,1995-11-29T05:00:00Z,1995,11,,,2008-05-30T22:53:21Z,,0,0,0900006480475b28
FDA-1995-N-0049-0002,FDA,FDA-1995-N-0049,"Reference 1 - Humphreys, S., Contaminants, Standards, and Monitoring Branch (HFS-308F), Center for Food Safety and Applied Nutrition, Food and Drug Administration, memo to Shellee Davis, May 26, 1995.",Notice,NPR-Notice of Proposed Rule-Making,1995-11-29T05:00:00Z,1995,11,,,2024-07-16T14:13:41Z,,0,0,0900006480561ccb
FDA-1995-G-0040-0001,FDA,FDA-1995-G-0040,Amoco Bioproducts Corp.,Notice,NFL-Notice of Filing,1995-11-28T05:00:00Z,1995,11,1995-10-23T04:00:00Z,1996-01-09T04:59:59Z,2008-05-16T22:22:17Z,,0,0,0900006480560ff7
FDA-1980-N-0074-0033,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:52:47Z,,0,0,09000064805bb3c8
FDA-1980-N-0074-0034,FDA,FDA-1980-N-0074,FDA,Notice,NFR-Notice of Final Rule,1995-11-27T05:00:00Z,1995,11,,,2008-05-30T22:53:02Z,,0,0,09000064805bb3c9
FDA-1995-N-0014-0001,FDA,FDA-1995-N-0014,FDA,Notice,NCR-Notice of Correction,1995-09-25T04:00:00Z,1995,9,1995-09-25T04:00:00Z,1995-10-31T04:59:59Z,2008-05-16T22:22:27Z,,0,0,09000064805584ac
FDA-1995-N-0021-0001,FDA,FDA-1995-N-0021,FDA,Notice,NPR-Notice of Proposed Rule-Making,1995-09-21T04:00:00Z,1995,9,1995-09-21T04:00:00Z,1995-11-07T04:59:59Z,2008-05-16T22:22:34Z,,0,0,09000064805594aa
FDA-1995-G-0001-0001,FDA,FDA-1995-G-0001,"Notice of Filing Solvay Enzymes, Inc. Filing of Petition for Affirmation of GRAS Status",Notice,Notice of Filing,1995-08-31T04:00:00Z,1995,8,1995-08-31T04:00:00Z,1995-11-02T04:59:59Z,2016-04-12T19:31:18Z,,0,0,090000648055830b
FDA-1991-N-0037-0004,FDA,FDA-1991-N-0037,FDA,Notice,NCR-Notice of Correction,1995-08-30T04:00:00Z,1995,8,,,2008-05-16T23:40:33Z,,0,0,0900006480529fdd
FDA-1995-N-0031-0003,FDA,FDA-1995-N-0031,"Notice of Correction re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products",Notice,Correction,1995-08-24T04:00:00Z,1995,8,,,2016-02-12T19:14:24Z,,0,0,090000648055a826
FDA-1990-N-0002-0006,FDA,FDA-1990-N-0002,FDA,Notice,NM-Notice of Meeting,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-10-24T03:59:59Z,2008-05-16T23:46:02Z,,0,0,090000648052558a
FDA-1995-M-0007-0001,FDA,FDA-1995-M-0007,Tab B: Approval Letter from FDA CDRH to Chiron Vision Corporation,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:33:30Z,,0,0,0900006480558409
FDA-1995-M-0007-0002,FDA,FDA-1995-M-0007,Tab C: Summary of Safety and Effectiveness Data,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:34:56Z,,0,0,090000648055840b
FDA-1995-M-0007-0003,FDA,FDA-1995-M-0007,Chiron Vision Corp.; Premarket Approval of Adatomed Silicone Oil OP5000,Notice,Notice of Approval,1995-07-27T04:00:00Z,1995,7,1995-07-27T04:00:00Z,1995-08-22T03:59:59Z,2024-06-27T16:29:51Z,95-17832,0,0,090000648055840c
FDA-1991-N-0037-0003,FDA,FDA-1991-N-0037,FDA,Notice,NAD-Notice of Availability of Data,1995-07-26T04:00:00Z,1995,7,,,2008-05-16T23:40:33Z,,0,0,0900006480529fda
FDA-1981-F-0038-0001,FDA,FDA-1981-F-0038,Food Additives Permitted for Direct Addition to Food for Human Consumption; Epoxidized Soybean Oil,Notice,Notice of Final Rule,1995-06-29T04:00:00Z,1995,6,1995-06-29T04:00:00Z,1995-07-27T03:59:59Z,2021-03-02T15:20:02Z,95-15349,0,0,09000064805af256
FDA-1995-P-0035-0001,FDA,FDA-1995-P-0035,FDA,Notice,NAD-Notice of Availability of Data,1995-06-20T04:00:00Z,1995,6,,,2008-05-16T23:07:26Z,,0,0,090000648055aed4
FDA-1992-N-0049-0002,FDA,FDA-1992-N-0049,Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period,Notice,NEC-Notice of Extension,1995-06-07T04:00:00Z,1995,6,1995-06-07T04:00:00Z,1995-07-18T03:59:59Z,2010-02-25T18:34:06Z,,0,0,090000648052bd0a
FDA-1995-M-0055-0001,FDA,FDA-1995-M-0055,Medtronlc CardloRhythm; Premarket Approval of Atakr Radio Frequency Catheter Ablation System,Notice,Notice of Approval,1995-05-03T04:00:00Z,1995,5,1995-05-03T04:00:00Z,1995-05-31T03:59:59Z,2024-06-12T20:00:38Z,,0,0,090000648056c1d8
FDA-1981-N-0015-0001,FDA,FDA-1981-N-0015,Over-the-Counter Dental and Oral Health Care Drug Products for Antiplaque Use; Safety and Efficacy Review; Request for Data and Information,Notice,Requests for Information (RFI),1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-03-19T04:59:59Z,2023-03-31T12:55:51Z,,0,0,09000064805aecdc
FDA-1981-N-0015-0004,FDA,FDA-1981-N-0015,Notice of Extension from FDA/CDER re over the couter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period,Notice,Notice of Extension,1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-06-18T03:59:59Z,2015-06-09T18:22:26Z,,0,0,09000064805aecfa
FDA-1981-N-0015-0003,FDA,FDA-1981-N-0015,Notice of Extension from FDA CDER re Over the counter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period,Notice,Notice of Extension,1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-06-18T03:59:59Z,2015-05-27T16:23:27Z,,0,0,09000064805aecf9
FDA-1981-N-0015-0002,FDA,FDA-1981-N-0015,Over-the-Counter Dental and Oral Health Care Drug Products for Antiplaque Use; Safety and Efficacy Review; Request for Data and Information,Notice,Requests for Information (RFI),1995-05-02T04:00:00Z,1995,5,1995-05-02T04:00:00Z,1991-03-19T04:59:59Z,2023-03-31T12:56:48Z,,0,0,09000064805aece2
FDA-1995-E-0065-0001,FDA,FDA-1995-E-0065,Determination of Regulatory Review Period for Purposes of Patent Extension; SERZONE®,Notice,Determinations,1995-04-27T04:00:00Z,1995,4,1995-04-24T04:00:00Z,1995-06-24T03:59:59Z,2017-10-13T13:51:35Z,95-10077,0,0,090000648056cd01
FDA-1979-N-0029-0014,FDA,FDA-1979-N-0029,Exocrine Pancreatic Insufficiency Drug Products for Over-the-Counter Human Use,Notice,Notice of Final Rule,1995-04-27T04:00:00Z,1995,4,,,2022-02-16T15:08:39Z,95-10078,0,0,0900006480553b5b
FDA-1995-E-0064-0001,FDA,FDA-1995-E-0064,FDA,Notice,N-Notice,1995-04-27T04:00:00Z,1995,4,1995-04-27T04:00:00Z,1995-06-24T03:59:59Z,2008-05-16T22:21:49Z,,0,0,090000648056ccdf
FDA-1994-M-0011-0002,FDA,FDA-1994-M-0011,"Exogen, Inc.; Premarket Approval of Sonic Accelerated Fracture Healing System (SAFHS); Correction",Notice,Correction,1995-04-11T04:00:00Z,1995,4,,,2024-06-07T15:09:12Z,95-7744,0,0,09000064804fc70c
FDA-1994-D-0004-0001,FDA,FDA-1994-D-0004,FDA,Notice,N-Notice,1995-04-03T04:00:00Z,1995,4,,,2008-05-16T23:11:38Z,,0,0,09000064804fc518
FDA-1993-F-0046-0002,FDA,FDA-1993-F-0046,Secondary Direct Food Additives Permitted in Food for Human Consumption,Notice,Notice of Final Rule,1995-03-07T05:00:00Z,1995,3,1995-03-07T05:00:00Z,1995-04-04T03:59:59Z,2024-05-22T15:48:25Z,95-5275,0,0,09000064804fc4a1
FDA-1980-N-0067-0001,FDA,FDA-1980-N-0067,Vaginal Contraceptive Drug Products for Over-the-Counter Human Use,Notice,NPR-Notice of Proposed Rule-Making,1995-02-09T05:00:00Z,1995,2,1995-02-09T05:00:00Z,1995-06-06T03:59:59Z,2022-06-28T01:00:22Z,95-2631,0,0,09000064805baf9a
FDA-1993-N-0043-0003,FDA,FDA-1993-N-0043,"Adverse Experience Reporting Requirements for Human Drug, Correction",Notice,Correction,1995-01-24T05:00:00Z,1995,1,,,2024-04-29T14:55:05Z,,0,0,09000064804fc3ce
FDA-1994-N-0037-0003,FDA,FDA-1994-N-0037,FDA,Notice,NM-Notice of Meeting,1995-01-11T05:00:00Z,1995,1,1995-01-11T05:00:00Z,1995-02-14T04:59:59Z,2008-05-16T23:15:38Z,,0,0,09000064804fd802